Authors: Muffazal A Lakdawala Aparna Bhasker Dheeraj Mulchandani Sunita Goel Sneha Jain
Publish Date: 2009/10/03
Volume: 20, Issue: 1, Pages: 1-6
Abstract
Laparoscopic sleeve gastrectomy LSG is gaining popularity as a procedure for the treatment of morbid obesity Its indications and longterm results are currently under evaluation Initially started as a firststage procedure for superobese patients it is now emerging as a standalone procedure in Asia and other parts of the world Early results suggest that at the end of 1 year weight loss and resolution of comorbidities with LSG is comparable to laparoscopic RouxenY gastric bypass LRYGB Whether LSG alone can replace LRYGB as a standard bariatric procedure is questionable The aim of this study is to compare the results resolution of comorbidities and complications between LSG and LRYGBA retrospective comparative analysis was done of 50 patients in each arm who underwent LSG and LRYGB from October 2007 to March 2008 Both groups were matched for age sex and body mass index The resolution of comorbidities percentage of excess weight loss EWL and complications were studied at 6 months and 1 year in our studyIt was seen that resolution of most comorbidities such as type 2 diabetes hypertension dyslipidemia sleep apnea joint pains and percentage of EWL in both groups was comparable at the end of 6 months and 1 year Though early resolution of type 2 diabetes was seen to be better in the LRYGB group the results matched up at 1 year There was increased incidence of gastroesophageal reflux disease in LSG patients On comparison it was also observed that the Asian studies have shown better results with LSG when compared to studies done in a largely Caucasian population
Keywords: